Mayank Bansal is a CFA Charterholder and heads the Equity Research team at Kapitales Research, with over 5 years of experience analysing global equity markets. He leads fundamental, data-driven research combining rigorous financial analysis with macro trends.
3 ASX Small Caps Jump as a Queensland Drilling Result, AI Data Growth and Gold Assay Demand Lift Investor Sentiment
Source: Kapitales Research
Highlights:
An oil and gas explorer reported that Queensland's deepest well found 191 metres of net pay, extending its promising play 25 kilometres north.
An AI data services provider lifted quarterly revenue 34% to US$73.9 million and returned one of its two divisions to profit.
A gold analysis technology company reported 27% revenue growth for the first four months of the financial year and reaffirmed its guidance.
Introduction
Three ASX-listed companies drew strong buying this week after fresh updates released between 29 October and 19 November 2026. Each tells a different growth story, spanning energy exploration, artificial intelligence and mining technology.
Stocks in Focus
Omega Oil & Gas Limited (ASX: OMA) is currently trading at AU$0.72.
Appen Limited (ASX: APX) is currently trading at AU$1.21.
Chrysos Corporation Limited (ASX: C79) is currently trading at AU$6.70.
Explorer Extends Its Taroom Trough Play
On 19 November 2026, Omega announced wireline logging results from Canyon North-1, the deepest well ever drilled in Queensland. The well found a 1,129-metre oil and gas-bearing sequence with 191 metres of net pay, suggesting the play reaches 25 kilometres north of the company's Canyon area. The Muggleton Formation measured 649 metres, the thickest seen so far. No flow testing has been done, and the company stresses that the multi-billion-barrel potential is not a resource estimate. Canyon North-2 starts in late November, with horizontal drilling and flow testing planned for the first half of 2027.
AI Data Provider Posts Stronger Quarter
In its 29 October 2026 quarterly report, Appen said revenue for the three months to 30 September reached US$73.9 million, while underlying EBITDA was US$10.3 million. Appen China grew revenue 61% to US$46.1 million. Appen Global returned to profit with US$5.6 million of EBITDA, helped by two new frontier AI customers. It now serves seven of the eight largest US model builders. Full-year guidance of US$270 to US$300 million in revenue was maintained, though revenue is likely in the lower half of that range. Cash stood at US$42.6 million.
Gold Assay Specialist Reaffirms Outlook
At its 19 November 2026 pre-AGM update, Chrysos reported unaudited revenue of AU$36.7 million for July to October, up 27%. Samples analysed reached 4.91 million, up 43%. Fifty-one PhotonAssay units are now deployed and 97 are contracted, already above the target of 90 deployed units by the end of FY29. The company holds a AU$139.5 million funding position and is operating cash-flow positive. It reaffirmed FY27 guidance of AU$108 to AU$118 million in revenue and AU$35 to AU$42 million in EBITDA.
Outro
From exploration upside to AI-driven demand and mining technology adoption, these updates gave investors plenty to weigh. Each company still has milestones ahead that will test its momentum. This article is general information only and is not financial advice.
Note: All data presented is based on information available at the time of writing.
Disclaimer for Kapitales Research
The materials provided by Kapitales Research, including articles, news, data, reports, opinions, images, charts, and videos ("Content"), are intended for personal, non-commercial use only. The primary goal of this Content is to educate and inform readers. This Content is not meant to offer financial advice, nor does it include any recommendation or opinion that should be relied upon for making financial decisions. Certain Content on this platform may be sponsored or unsponsored, but it does not serve as a solicitation or endorsement to buy, sell, or hold any securities, nor does it encourage any specific investment activities. Kapitales Research is not authorized to provide investment advice, and we strongly advise users to seek guidance from a qualified financial professional, such as a financial advisor or stockbroker, before making any investment choices. Kapitales Research disclaims all liability for any direct, indirect, incidental, or consequential damages arising from the use of the Content, which is provided without any warranties. The opinions expressed by contributors or guests are their own and do not necessarily reflect the views of Kapitales Research. Media such as images or music used on this platform are either owned by Kapitales Research, sourced through paid subscriptions, or believed to be in the public domain. We have made reasonable efforts to credit sources where appropriate. Kapitales Research does not claim ownership of any third-party media unless explicitly stated otherwise.
Customer Notice:
Nextgen Global Services Pty Ltd trading as Kapitales Research (ABN 89 652 632 561) is a Corporate Authorised Representative (CAR No. 1293674) of Enva Australia Pty Ltd (AFSL 424494). The information contained in this website is general information only. Any advice is general advice only. No consideration has been given or will be given to the individual investment objectives, financial situation or needs of any particular person. The decision to invest or trade and the method selected is a personal decision and involves an inherent level of risk, and you must undertake your own investigations and obtain your own advice regarding the suitability of this product for your circumstances. Please be aware that all trading activity is subject to both profit & loss and may not be suitable for you. The past performance of this product is not and should not be taken as an indication of future performance.Disclosure: The information mentioned above has been sourced from the company reports and a third-party database, i.e. Koyfin. Investors are advised to use strict stop-loss to protect their investments in case of any unfavorable/uncertain market events.
Kapitales Research, Level 13, Suite 1A, 465 Victoria Ave, Chatswood, NSW 2067, Australia | 1800 005 780 | info@kapitales.com.au
We use cookies to help us improve, promote, and protect our services.
By continuing to use this site, we assume you consent to this.
Read our
Privacy Policy
and
Terms & Conditions
3 ASX Small Caps Jump as a Queensland Drilling Result, AI Data Growth and Gold Assay Demand Lift Investor Sentiment
Highlights:
An oil and gas explorer reported that Queensland's deepest well found 191 metres of net pay, extending its promising play 25 kilometres north.
An AI data services provider lifted quarterly revenue 34% to US$73.9 million and returned one of its two divisions to profit.
A gold analysis technology company reported 27% revenue growth for the first four months of the financial year and reaffirmed its guidance.
Introduction
Three ASX-listed companies drew strong buying this week after fresh updates released between 29 October and 19 November 2026. Each tells a different growth story, spanning energy exploration, artificial intelligence and mining technology.
Stocks in Focus
Omega Oil & Gas Limited (ASX: OMA) is currently trading at AU$0.72.
Appen Limited (ASX: APX) is currently trading at AU$1.21.
Chrysos Corporation Limited (ASX: C79) is currently trading at AU$6.70.
Explorer Extends Its Taroom Trough Play
On 19 November 2026, Omega announced wireline logging results from Canyon North-1, the deepest well ever drilled in Queensland. The well found a 1,129-metre oil and gas-bearing sequence with 191 metres of net pay, suggesting the play reaches 25 kilometres north of the company's Canyon area. The Muggleton Formation measured 649 metres, the thickest seen so far. No flow testing has been done, and the company stresses that the multi-billion-barrel potential is not a resource estimate. Canyon North-2 starts in late November, with horizontal drilling and flow testing planned for the first half of 2027.
AI Data Provider Posts Stronger Quarter
In its 29 October 2026 quarterly report, Appen said revenue for the three months to 30 September reached US$73.9 million, while underlying EBITDA was US$10.3 million. Appen China grew revenue 61% to US$46.1 million. Appen Global returned to profit with US$5.6 million of EBITDA, helped by two new frontier AI customers. It now serves seven of the eight largest US model builders. Full-year guidance of US$270 to US$300 million in revenue was maintained, though revenue is likely in the lower half of that range. Cash stood at US$42.6 million.
Gold Assay Specialist Reaffirms Outlook
At its 19 November 2026 pre-AGM update, Chrysos reported unaudited revenue of AU$36.7 million for July to October, up 27%. Samples analysed reached 4.91 million, up 43%. Fifty-one PhotonAssay units are now deployed and 97 are contracted, already above the target of 90 deployed units by the end of FY29. The company holds a AU$139.5 million funding position and is operating cash-flow positive. It reaffirmed FY27 guidance of AU$108 to AU$118 million in revenue and AU$35 to AU$42 million in EBITDA.
Outro
From exploration upside to AI-driven demand and mining technology adoption, these updates gave investors plenty to weigh. Each company still has milestones ahead that will test its momentum. This article is general information only and is not financial advice.
Note: All data presented is based on information available at the time of writing.
Disclaimer for Kapitales Research
The materials provided by Kapitales Research, including articles, news, data, reports, opinions, images, charts, and videos ("Content"), are intended for personal, non-commercial use only. The primary goal of this Content is to educate and inform readers. This Content is not meant to offer financial advice, nor does it include any recommendation or opinion that should be relied upon for making financial decisions. Certain Content on this platform may be sponsored or unsponsored, but it does not serve as a solicitation or endorsement to buy, sell, or hold any securities, nor does it encourage any specific investment activities. Kapitales Research is not authorized to provide investment advice, and we strongly advise users to seek guidance from a qualified financial professional, such as a financial advisor or stockbroker, before making any investment choices. Kapitales Research disclaims all liability for any direct, indirect, incidental, or consequential damages arising from the use of the Content, which is provided without any warranties. The opinions expressed by contributors or guests are their own and do not necessarily reflect the views of Kapitales Research. Media such as images or music used on this platform are either owned by Kapitales Research, sourced through paid subscriptions, or believed to be in the public domain. We have made reasonable efforts to credit sources where appropriate. Kapitales Research does not claim ownership of any third-party media unless explicitly stated otherwise.
Customer Notice:
Nextgen Global Services Pty Ltd trading as Kapitales Research (ABN 89 652 632 561) is a Corporate Authorised Representative (CAR No. 1293674) of Enva Australia Pty Ltd (AFSL 424494). The information contained in this website is general information only. Any advice is general advice only. No consideration has been given or will be given to the individual investment objectives, financial situation or needs of any particular person. The decision to invest or trade and the method selected is a personal decision and involves an inherent level of risk, and you must undertake your own investigations and obtain your own advice regarding the suitability of this product for your circumstances. Please be aware that all trading activity is subject to both profit & loss and may not be suitable for you. The past performance of this product is not and should not be taken as an indication of future performance.Disclosure: The information mentioned above has been sourced from the company reports and a third-party database, i.e. Koyfin. Investors are advised to use strict stop-loss to protect their investments in case of any unfavorable/uncertain market events.
Kapitales Research, Level 13, Suite 1A, 465 Victoria Ave, Chatswood, NSW 2067, Australia | 1800 005 780 | info@kapitales.com.au